AdvisorNet Financial, Inc - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2023$69,195
+15.0%
1,5000.0%0.01%0.0%
Q1 2023$60,150
-13.4%
1,5000.0%0.01%
-14.3%
Q4 2022$69,495
+12.1%
1,5000.0%0.01%
+16.7%
Q3 2022$62,000
-30.3%
1,5000.0%0.01%
-33.3%
Q2 2022$89,000
-18.3%
1,5000.0%0.01%
+28.6%
Q1 2022$109,000
-13.5%
1,5000.0%0.01%
-12.5%
Q4 2021$126,000
-6.7%
1,5000.0%0.01%
-11.1%
Q3 2021$135,000
-5.6%
1,5000.0%0.01%0.0%
Q2 2021$143,000
-16.4%
1,5000.0%0.01%
-25.0%
Q1 2021$171,000
-17.8%
1,5000.0%0.01%
-29.4%
Q4 2020$208,000
+69.1%
1,5000.0%0.02%
+54.5%
Q3 2020$123,000
+5.1%
1,5000.0%0.01%
+22.2%
Q2 2020$117,000
+74.6%
1,5000.0%0.01%
+50.0%
Q1 2020$67,000
+4.7%
1,5000.0%0.01%
+20.0%
Q4 2019$64,000
-47.5%
1,500
-47.4%
0.01%
-54.5%
Q3 2019$122,000
-32.6%
2,8500.0%0.01%
-45.0%
Q2 2019$181,000
-8.6%
2,8500.0%0.02%
-16.7%
Q1 2019$198,000
+59.7%
2,8500.0%0.02%
+41.2%
Q4 2018$124,000
-26.2%
2,850
+29.5%
0.02%
-19.0%
Q3 2018$168,000
-0.6%
2,2000.0%0.02%
-8.7%
Q2 2018$169,000
+50.9%
2,2000.0%0.02%
+53.3%
Q1 2018$112,000
+9.8%
2,2000.0%0.02%0.0%
Q4 2017$102,0002,2000.02%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2023
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$4,658,0002.63%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,364,434$84,745,0001.21%
CAPITAL INTERNATIONAL LTD /CA/ 259,700$16,130,0001.07%
Aureus Asset Management, LLC 65,670$4,079,0000.69%
Capital International Sarl 124,320$7,722,0000.67%
CAPITAL GUARDIAN TRUST CO 512,430$31,827,0000.58%
ROCKEFELLER FINANCIAL SERVICES INC 408,379$25,365,0000.50%
Rock Springs Capital Management LP 160,500$9,969,0000.50%
Hood River Capital Management LLC 112,296$6,975,0000.48%
Capital International, Inc./CA/ 52,700$3,273,0000.47%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders